Clinical Trials Directory

Trials / Terminated

TerminatedNCT04059458

Mandibular Furcation III Regeneration (FURC-III-REGEN)

Biphasic Calcium Phosphate and a Collagen Membrane or Biphasic Calcium Phosphate and Enamel Matrix Proteins, in the Regenerative Treatment of Furcation Grade III Defects

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of Oslo · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Teeth with furcation grade III defects will be treated with open flap debridement and regenerative therapy with biphasic calcium phosphate combined with either enamel matrix proteins or a collagen membrane.

Conditions

Interventions

TypeNameDescription
DEVICEBiphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane)Device: Biphasic calcium phosphate (Straumann Bone Ceramic) + collagen membrane (Straumann Jason Membrane) Following open flap debridement of mandibular grade II furcation defects, regenerative therapy is performed with biphasic calcium phosphate + collagen membrane.
DRUGBiphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)Drug: Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain) Following open flap debridement of mandibular grade II furcation defects, regenerative therapy is performed with biphasic calcium phosphate + enamel matrix proteins.

Timeline

Start date
2019-10-15
Primary completion
2023-11-27
Completion
2023-11-27
First posted
2019-08-16
Last updated
2023-11-30

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT04059458. Inclusion in this directory is not an endorsement.

Mandibular Furcation III Regeneration (FURC-III-REGEN) (NCT04059458) · Clinical Trials Directory